In this issue: Calls for closer ties between the NHS and pharma, Norway’s...
Case Study: Assessing Potential for Oral Delivery Using Parallel Screening
Catalent utilised two technologies targeting duodenal and sublingual biological barriers through a parallel screening approach to assess the oral delivery potential of Salmon Calcitonin.
Enhanced Sampling and Calibration Procedures for Analysis of Residual Oxygen in Nitrogen Purged Pharmaceutical Packaging by GC-TCD
In recent times, there has been a large increase in the type and number of products packaged using modified atmosphere packaging (MAP) procedures.
bb2121 receives EMA PRIME eligibility and FDA BTD for multiple myeloma
The European Medicines Agency (EMA) has granted priority medicines (PRIME) eligibility for bb2121 to treat patients with relapsed and refractory multiple myeloma.
Cue Biopharma and Merck to develop biologics for autoimmune diseases
US-based company Cue Biopharma has entered a strategic research collaboration and licence agreement with Merck to focus on the development of new biologics for the treatment of autoimmune diseases.
Liposomes protect, transport and release your drug at the right place and time. By this, a reduced dose achieves better efficacy and avoids side effects with a non-invasive application. A liposomal formulation can clearly improve the therapeutic index of your drug.
Calculating Pressure, Pipe Measurement, and Flow Rate Requirements for a Non-Newtonian Fluid
When pumping fluids over long distances, the required pressure, pipe diameter, and flow rate is calculated. For non-Newtonian fluids, it is sufficient to consider them as power law fluids, in terms of processing, due to the shear rates.
Support for the use of Inflectra in Crohn’s disease
A recent report shows patients suffering from Crohn’s disease (CD) who changed their treatment from Remicade to Inflectra experienced comparable efficacy, safety and tolerability to treatment over a six-month period.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.